Clinical Treating Thromboangiitis Obliterans with Huomai Powder

ZHENG Xue-jun1; FAN Kai-fang2; ZHANG Xiao-li1; LI Xiao-liang1

doi:10.13422/j.cnki.syfjx.2012.18.012

您当前的位置：

首页 >

文章列表页 >

Clinical Treating Thromboangiitis Obliterans with Huomai Powder

更新时间：2024-09-23

- Clinical Treating Thromboangiitis Obliterans with Huomai Powder
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 18, Issue 18, Pages: 295-298(2012)
- 作者机构：
  
  1. 山西中医学院附属医院
  2. 山西中医学院
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.2012.18.012
  CLC： R259
- Published：2012
- 稿件说明：
移动端阅览
[1]郑学军,樊凯芳,张晓丽,李晓亮.活脉散治疗血栓闭塞性脉管炎[J].中国实验方剂学杂志,2012,18(18):295-298.

ZHENG Xue-jun1, FAN Kai-fang2, ZHANG Xiao-li1, et al. Clinical Treating Thromboangiitis Obliterans with Huomai Powder[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(18): 295-298.
[1]郑学军,樊凯芳,张晓丽,李晓亮.活脉散治疗血栓闭塞性脉管炎[J].中国实验方剂学杂志,2012,18(18):295-298. DOI： 10.13422/j.cnki.syfjx.2012.18.012.

ZHENG Xue-jun1, FAN Kai-fang2, ZHANG Xiao-li1, et al. Clinical Treating Thromboangiitis Obliterans with Huomai Powder[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(18): 295-298. DOI： 10.13422/j.cnki.syfjx.2012.18.012.

摘要

目的:观察活脉散治疗血栓闭塞性脉管炎的疗效。方法:采用随机、对照研究的方法

将90例血脉瘀阻型血栓闭塞性脉管炎患者分为3组治疗。治疗组30例

常规西医治疗加口服活脉散;对照1组30例

常规西医治疗加口服血府逐瘀胶囊

对照2组30例

单纯应用前列地尔、降纤酶。结果:治疗组在临床疗效方面优于2个对照组

3组比较有显著性差异（P<0.05）。治疗组治疗前后ABI

FIB有显著性差异（P<0.05）。结论:采用活脉散为主的治疗方法效果优于血府逐瘀胶囊为主的治疗方法。活脉散是治疗血栓闭塞性脉管炎血脉瘀阻证有效的药物。

Abstract

Objective:To observe the effect of Huomai powder on thromboangiitis obliterans.Method:Ninety subjects who suffered from thromboangiitis obliterans with syndrome of blood stasis were divided into three groups:treatment group（30 cases）

given routine treatment of western medicine and Huomai powder;control group 1（30 cases）

given Routine treatment of western medicine and Xuefu Zhuyu capsule;control group 2（30 cases）

given routine treatment of western medicine.Result:In the clinical efficacy

the treatment group was better than the control group（P<0.05）.The treatment group before and after treatment with ABI

FIB had significant difference（P<0.05）.Conclusion:The treatment group was more effective than control group.Huomai powder was effective in treating thromboangiitis obliterans with syndrome of blood stasis.

关键词

Keywords

references

Views

154

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Clinical Treating Thromboangiitis Obliterans with Huomai Powder

Effect of Sanshencao Essential Oil on Rat Model of Thromboangiitis Obliterans

Clinical Observation of Rongshuan Tongluo Capsule in Treatment of Thromboangiitis Obliterans

Mechanism of Shenfu Injection Alleviating Lesions in Experimental Buerger's Disease Model Rats

Related Author

LI Xiao-liang

ZHANG Xiao-li

FAN Kai-fang

ZHENG Xue-jun

Shuo TIAN

Ming-san MIAO

Jing LIU

LI Rui-lin

Related Institution

Henan University of Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰